Treatment of severe and fulminant inflammatory bowel disease colitis

Dominic Vitello, Michael F. McGee*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Despite dramatic advances in medical treatment of inflammatory colitis, a substantial proportion of patients with ulcerative colitis (UC) and isolated Crohn's disease (CD) colitis will acutely develop severe disease requiring hospitalization and surgery. It is imperative that surgeons understand the multidisciplinary nuances at the intersection between medical and surgical management. It is important that the surgeon be able to evaluate and stratify the severity of inflammatory bowel disease (IBD) colitis, understand medical treatment options, monitor responses to medical therapy, and ultimately execute timely and appropriate surgery for these often-ill patients.

Original languageEnglish (US)
Article number100864
JournalSeminars in Colon and Rectal Surgery
Volume33
Issue number1
DOIs
StatePublished - Mar 2022

Funding

None.

Keywords

  • Crohn's disease
  • Fulminant colitis
  • Total abdominal colectomy
  • Toxic megacolon
  • Ulcerative colitis

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology

Fingerprint

Dive into the research topics of 'Treatment of severe and fulminant inflammatory bowel disease colitis'. Together they form a unique fingerprint.

Cite this